PASITHEA THERAPEUTICS CORP. Acquisitions, Net of Cash Acquired
PASITHEA THERAPEUTICS CORP. (KTTA) reported Acquisitions, Net of Cash Acquired of $2.19 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2024-03-29
- PASITHEA THERAPEUTICS CORP. payments to acquire businesses, net of cash acquired for the quarter ending 2022-12-31 was $2.25M.
- PASITHEA THERAPEUTICS CORP. payments to acquire businesses, net of cash acquired for the quarter ending 2022-09-30 was $20.48K.
- PASITHEA THERAPEUTICS CORP. payments to acquire businesses, net of cash acquired for fiscal 2022 was $2.19M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $2.27M derived: sum of 2 quarters · filed 2024-03-29 | $2.19M 10-K · filed 2024-03-29 | -$77.06K 10-K · filed 2023-03-30 | ||
| 2022-09-30 | $20.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$56.58K 10-Q · filed 2023-11-13 | -$44.08K 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | -$77.06K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |